Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Response from PTSC IR on Shareholders meeting

< Any announcement of dividends that is "await[ing] a certain negotiation outcome" would be dependent upon the litigation events I mentioned such as Markman rulings,

Are you saying that a fourth Markman is necessary before we can obtain any new licenses or settlements? Three are insufficiant?

<motion practice>

I had no idea what that was when you first mentioned it, and still don't.

< The Company has paid dividends before,>

Not only have paid them before, but gave an indication that is the plan for the future. You would rather any decision as to what PTSC does with future income be decided by PTSC management?>

Opty


Share
New Message
Please login to post a reply